OLAPLEX Reports First Quarter 2026 Results

Olaplex is being acquired after a weak quarter, not because of strong performance.

What the company is saying

Olaplex Holdings, Inc. is positioning its first quarter 2026 results as a 'solid start to the year,' emphasizing positive sell-through and the successful launch of No. 3 PLUS. The company wants investors to believe that disciplined operational execution and transformation priorities are driving improved performance, even as it transitions toward acquisition by Henkel AG & Co. KGaA. The announcement highlights a 2.5% increase in net sales to $99.4 million, with strong growth in Professional and Direct-To-Consumer channels, and frames the acquisition as a significant premium for shareholders—55% above the prior closing price and 45% above the 30-day VWAP. However, the release buries the fact that profitability has deteriorated: net income swung from a $0.5 million profit to a $5.3 million loss, and adjusted EBITDA fell sharply. There is no mention of the underlying causes for rising costs or the operational challenges behind the loss. The tone is neutral but leans positive, with management—specifically CEO Amanda Baldwin—projecting confidence in the transformation narrative while avoiding any discussion of the negative bottom line. The absence of a conference call or updated guidance is justified by the pending acquisition, effectively limiting investor scrutiny. This narrative fits a classic playbook for companies being acquired after operational underperformance: focus on topline growth and the acquisition premium, while minimizing discussion of deteriorating fundamentals. Compared to prior communications (where available), the messaging is more defensive and transactional, with less forward-looking optimism and more emphasis on the certainty of the buyout.

What the data suggests

The disclosed numbers show that while net sales grew modestly by 2.5% year-over-year ($99.4 million in Q1 2026 vs. $97.0 million in Q1 2025), profitability metrics worsened significantly. Gross profit margin improved to 72.1% from 69.5%, but this was offset by a sharp increase in SG&A expenses, which rose from $48.0 million to $66.0 million—a 37% jump. As a result, net income swung from a $0.5 million profit to a $5.3 million net loss, and adjusted EBITDA dropped from $25.7 million to $19.0 million, with the margin falling from 26.5% to 19.1%. Adjusted net income also declined from $13.2 million to $10.6 million. Segment data reveals that Specialty Retail sales fell 13.3%, while Professional and Direct-To-Consumer channels grew by 12.3% and 13.8%, respectively. U.S. sales declined 3.5%, while international sales rose 8.6%. The company’s cash position improved slightly to $326.2 million, and inventory increased to $66.4 million. No updated guidance or future targets are provided, and the company will not host a conference call, limiting transparency. An independent analyst would conclude that, despite modest sales growth and a strong gross margin, the company’s cost structure is out of control, leading to deteriorating profitability and raising questions about the sustainability of the business absent the acquisition.

Analysis

The announcement combines factual financial results with positive narrative framing. Most key claims are realised and supported by numerical data, such as the 2.5% net sales increase and the definitive acquisition agreement. However, the language describing 'a solid start to the year' and 'disciplined operational execution' is not substantiated by the underlying financials, as the company swung from a small profit to a net loss and saw declining adjusted EBITDA. The only forward-looking elements are generic cautionary statements and references to business transformation plans, with no specific projections or guidance. The acquisition is a signed, binding agreement, so the benefits are not aspirational. The gap between narrative and evidence is moderate: positive tone is used despite deteriorating profitability, but there is no extreme hype or unsubstantiated future promises.

Risk flags

• ●Operational risk is high, as evidenced by the sharp increase in SG&A expenses (up 37% year-over-year) and the swing from net income to net loss, suggesting cost controls are ineffective and the business model is under pressure.
• ●Financial risk is apparent in the declining profitability metrics: adjusted EBITDA fell by 26% and adjusted net income dropped by 19%, indicating that even with modest sales growth, the company cannot translate revenue into profit.
• ●Disclosure risk is elevated due to the company’s decision not to provide updated financial guidance or host a conference call, which limits investor ability to question management or understand the drivers of underperformance.
• ●Pattern-based risk is present in the narrative: management continues to use positive language ('solid start,' 'strong quarter') despite clear evidence of deteriorating financials, raising concerns about credibility and transparency.
• ●Timeline/execution risk is low for the acquisition itself, but high for any operational turnaround, as the company is no longer pursuing standalone improvement and all forward-looking operational claims are now irrelevant.
• ●Geographic risk is notable: U.S. sales declined 3.5% while international sales grew 8.6%, suggesting potential saturation or competitive pressure in the core domestic market.
• ●Capital intensity is not flagged as a risk in this context, as the acquisition is an all-cash transaction and does not require further capital deployment by Olaplex.
• ●Forward-looking risk remains, as the majority of operational claims are now moot and any value realization is entirely dependent on the successful closing of the acquisition; if the deal fails, the company is left with deteriorating fundamentals and no clear path to recovery.

Bottom line

For investors, this announcement means that Olaplex is being acquired at a significant premium to its recent trading price, providing a clear near-term exit at $2.06 per share. The company’s narrative of operational improvement is not supported by the underlying financials: profitability has deteriorated, costs are rising faster than sales, and the business swung to a net loss despite modest revenue growth. CEO Amanda Baldwin’s involvement signals continuity in messaging but does not change the fact that the company is being sold from a position of weakness, not strength. There are no notable institutional investors or strategic partners disclosed beyond the acquirer, so there is no additional signal from outside capital. To change this assessment, the company would need to provide evidence of sustainable profitability or operational turnaround, but this is now irrelevant given the pending acquisition. Investors should watch for any signs of the deal failing to close—such as regulatory pushback or shareholder dissent—as this is now the primary risk to value realization. All other operational or financial metrics are secondary, as the company will not provide further guidance or updates. The information in this announcement is actionable only insofar as it relates to the likelihood and timing of the acquisition closing; there is no standalone investment case for Olaplex as an independent entity. The single most important takeaway is that the acquisition premium is the only source of near-term value, and if the deal does not close, investors are left with a business facing deteriorating fundamentals and limited transparency.

Announcement summary

Olaplex Holdings, Inc. (NASDAQ: OLPX) announced its financial results for the first quarter ended March 31, 2026. Net sales increased 2.5% to $99.4 million compared to the first quarter of 2025, with notable growth in the Professional and Direct-To-Consumer channels. The company reported a net loss of $5.3 million, compared to net income of $0.5 million in the prior year period. On March 26, 2026, Olaplex entered into a definitive agreement to be acquired by Henkel AG & Co. KGaA for $2.06 per share in a cash transaction, representing an equity value of approximately $1.4 billion. Due to the pending acquisition, Olaplex will not host a conference call or provide updated financial guidance.

Disagree with this article?